Cephalexin is in a group of Cephalosporin antibiotics and is used to fight bacteria in the body. It acts by inhibiting the bacteria's formation of cell wall, which breaks the cell wall and kills the bacteria. It is indicated in Upper Respiratory Infections, Ear Infections, Skin Infections and Urinary Tract Infections.
CEFEL KID D. TABLETS
Cephalexin 125 mg.
Cephalexin is a Cephalosporin antibiotic and is used to fight bacteria in the body. It acts by inhibiting the bacteria's formation of cell wall, which breaks the cell wall and kills the bacteria. It is indicated in Upper Respiratory Infections, Ear Infections, Skin Infections and Urinary Tract Infections.
CEFEL 250 D. TABLETS
Cephalexin 250 mg.
Cephalexin is a Cephalosporin antibiotic and is used to fight bacteria in the body. It acts by inhibiting the bacteria's formation of cell wall, which breaks the cell wall and kills the bacteria. It is indicated in Upper Respiratory Infections, Ear Infections, Skin Infections and Urinary Tract Infections.
CEFEL 500 CAPSULES
Cephalexin 500 mg.
Cephalexin is a Cephalosporin antibiotic and is used to fight bacteria in the body. It acts by inhibiting the bacteria's formation of cell wall, which breaks the cell wall and kills the bacteria. It is indicated in Upper Respiratory Infections, Ear Infections, Skin Infections and Urinary Tract Infections.
Cefuroxime Formulations
Sayfur 125 D.Tablets
Cefuroxime 125 mg.
Sayfur contains Cefuroxime which belongs to second generation antibiotic. It acts by inhibiting protein synthesis. Its absorption increases with food. It is indicated in infections caused by staphylococci, H.influenzae, E.coli, Salmonella, Urinary tract infections, Early lime disease.
Sayfur 250 D.Tablets
Cefuroxime 250 mg.
Sayfur contains Cefuroxime which belongs to second generation antibiotic. Cefuroxime binds to penicillin-binding proteins (PBPs) which alters the last transpeptidation step of peptidoglycan synthesis, thus inhibits its biosynthesis and arrest cell wall assembly which causes death of bacterial cell. It is indicated in infections caused by staphylococci, H.influenzae, E.coli, Salmonella, Urinary tract infections, Early lime disease.
SAYFUR 500 D.TABLETS
Cefuroxime 500 mg.
Sayfur contains Cefuroxime which belongs to second generation antibiotic. It binds to penicillin-binding proteins (PBPs) which alters the last transpeptidation step of peptidoglycan synthesis, thus inhibits its biosynthesis and arrest cell wall assembly which causes death of bacterial cell. Its absorption increases with food. It is indicated in infections caused by staphylococci, H.influenzae, E.coli, Salmonella, Urinary tract infections, Early lime disease.
Cefine contains Cefixime. Cefixime belongs to third generation cephalosporin antibiotics. It inhibits cell wall synthesis by inhibiting final transpeptidation step of peptidoglycan synthesis. It has well established pharmacokinetic profile with absorption of 40 to 50 %. It is indicated in Urinary Tract Infections, Acute Otitis Media and also in Respiratory Infections. Cefine Dry Syrup is a dosage form for pediatric use in a palatable taste.
CEFINE 100 D. TABLETS
Cefixime 100 mg
Cefine contains Cefixime. Cefixime is cephalosporin antibiotics. It inhibits cell wall synthesis and thus prevent bacterial infection. It has well established pharmacokinetic profile with absorption of 40 to 50 %. It is indicated in Urinary Tract Infections, Acute Otitis Media and also in Respiratory Infections caused by S.pneumoniae, S.pyogenes, H.influenzae and also in bone and joint infections.
CEFINE 200 D. TABLETS
Cefixime 200 mg
Cefine contains Cefixime. Cefixime is third generation cephalosporin antibiotics. It inhibits cell wall synthesis by inhibiting final transpeptidation step of peptidoglycan synthesis in cell walls. It has well established pharmacokinetic and pharmacodynamic profile. It is indicated in Urinary Tract Infections, Acute Otitis Media and also in Respiratory Infections caused by S.pneumoniae, S.pyogenes, H.influenzae and also in bone and joint infections.
CEFPO DRY SYRUP
Cefpodoxime 50 mg/5 ml
Cefpo contains Cefpodoxime which belongs to third generation cephalosporin antibiotic. It inhibits cell wall synthesis by inhibiting final transpeptidation step of peptidoglycan synthesis in cell walls. It has well established pharmacokinetic profile with absorption of 50%. It is indicated in Community Acquired Pneumonia, Uncomplicated Skin and Skin Structure Infections and Uncomplicated Urinary Tract Infections.
CEFPO 50 D.TABLETS
Cefpodoxime 50 mg.
Cefpo contains Cefpodoxime. It belongs to third generation cephalosporin. It inhibits cell wall synthesis by inhibiting final transpeptidation step of peptidoglycan synthesis in cell walls. It has well established pharmacokinetic profile with absorption of 50%. It is indicated in Community Acquired Pneumonia, Uncomplicated Skin and Skin Structure Infections and Uncomplicated Urinary Tract Infections.
CEFPO 100 D. TABLETS
Cefpodoxime 100 mg.
Cefpo contains Cefpodoxime. It belongs to third generation cephalosporin. It inhibits cell wall synthesis by inhibiting final transpeptidation step of peptidoglycan synthesis in cell walls. It has well established pharmacokinetic profile with absorption of 50%. It is indicated in Community Acquired Pneumonia, Uncomplicated Skin and Skin Structure Infections and Uncomplicated Urinary Tract Infections.
CEFPO 200 TABLETS
Cefpodoxime 200 mg.
Cefpo contains Cefpodoxime. It belongs to third generation cephalosporin. It inhibits cell wall synthesis by inhibiting final transpeptidation step of peptidoglycan synthesis in cell walls. It has well established pharmacokinetic profile with absorption of 50%. It is indicated in Community Acquired Pneumonia, Uncomplicated Skin and Skin Structure Infections and Uncomplicated Urinary Tract Infections.
Cefpo Dx contains Cefpodoxime and Dicloxacilline. It is the combination of Cephalosporin which acts against broad range of gram +ve and gram -ve organisms and Dicloxacillin which acts against penicillinase producing gram +ve pathogens. It is indicated in Respiratory infection, Urinary tract infections, Bone infections and Skin infections.
FINETRIAX 250 INJECTION
Ceftriaxone 250 mg. Inj.
Finetriax contains Ceftriaxone. It belong to third generation Cephalosporin antibiotic. It inhibits bacterial cell growth. It is indicated in Urinary tract infections, Lower respiratory tract infections, Acute sinusitis, Skin and skin structure infections, Bone and Joint infections, Intra-abdominal infections and Meningitis.
FINETRIAX 500 INJECTION
Ceftriaxone 500 mg.Inj.
Finetriax contains Ceftriaxone which is a third-generation Cephalosporin antibiotic. It has broad spectrum activity against Gram-positive and Gram-negative bacteria. It is indicated in Urinary tract infections, Lower respiratory tract infections, Acute sinusitis, Skin and skin structure infections.
Finetriax contains Ceftriaxone. It belong to third generation Cephalosporin antibiotic. It inhibits bacterial cell growth. It is indicated in Urinary tract infections, Lower respiratory tract infections, Acute sinusitis, Skin and skin structure infections, Bone and Joint infections, Intra-abdominal infections and Meningitis.
F-TAAZ 1000 INJECTION
Ceftazidime 1000 mg. Inj.
F-Taaz contain Ceftazidime which is bactericidal in action, exerting its effect by inhibition of enzymes responsible for cell-wall synthesis. A wide range of gram-ve organisms is susceptible to ceftazidime in vitro, including strains resistant to gentamicin and other aminoglycosides. It is indicated in Respiratory Tract Infections (Upper and Lower), Urinary Tract Infections (Upper and Lower), Peritonitis, Cholecystitis, Cholangitis, and Other Intra-Abdominal Infections, Septicemia, Meningitis, Skin and Soft Tissue Infections
SAFEDINIR 125 D.TABLETS
Cefdinir 125 mg.
Safedinir brand contains Cefdinir which belongs to third generation Cephalosporin antibiotic. It acts by inhibiting protein synthesis where it inhibits transpeptidation step. It is indicated in Community acquired pneumonia, Acute Otitis Media, Acute maxillary sinusitis, Pharyngitis, Uncomplicated skin and skin structure infections.
SAFEDINIR 300 TABLETS
Cefdinir 300 mg.
Safedinir brand contains Cefdinir which belongs to third generation Cephalosporin antibiotic. It acts by inhibiting protein synthesis where it inhibits transpeptidation step. It is indicated in Community acquired pneumonia, Acute Otitis Media, Acute maxillary sinusitis, Pharyngitis, Uncomplicated skin and skin structure infections.
SAFEDINIR DRY SYRUP
Cefdinir 125 mg./5ml
Safedinir brand contains Cefdinir which belongs to third generation Cephalosporin antibiotic. It acts by inhibiting protein synthesis where it inhibits transpeptidation step. It is indicated in Community acquired pneumonia, Acute Otitis Media, Acute maxillary sinusitis, Pharyngitis, Uncomplicated skin and skin structure infections.
